Filter results
You can narrow down the results using the filters
Audience
Topics
Our work
Diseases
10925 results
-
Hepatitis D – Surveillance case definition
This document contains the surveillance case definition for hepatitis D, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Malaria – Surveillance case definition
This document contains the surveillance case definition for malaria, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Measles – Surveillance case definition
This document contains the surveillance case definition for measles, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Invasive pneumococcal disease – Surveillance case definition
This document contains the surveillance case definition for invasive pneumococcal disease, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Flavivirus infection (unspecified) including Zika virus – Surveillance case definition
This document contains the surveillance case definition for flavivirus infection (unspecified), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Campylobacteriosis – Surveillance case definition
This document contains the surveillance case definition for campylobacteriosis, which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case. -
Review of the national HIV/AIDS and hepatitis C strategies
Australian Government response to the 2002 reviews of the national HIV/AIDS and hepatitis C strategies -
Melioidosis – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for melioidosis. -
National Strategy for Quality Use of Medicines
This strategy sets out the approach we are taking to achieve quality use of medicines in Australia. The strategy recognises that many people do not need medicines to be healthy, while for others, medicines play an important role in maintaining health, preventing illness and curing disease. -
Indigenous health – 'Health is life'
Australian Government response to the House of Representatives Standing Committee on Family and Community Affairs inquiry into the health status of Indigenous Australians -
Voluntary agreement to disclose cigarette ingredients
A number of tobacco companies have voluntarily agreed to provide information about the ingredients in their cigarette products. -
Campylobacteriosis – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for campylobacteriosis. -
Tetanus – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for tetanus. -
Respiratory syncytial virus – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for respiratory syncytial virus. -
Australian bat lyssavirus infection – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for Australian bat lyssavirus infection. -
Shigellosis – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for shigellosis. -
Polio – Laboratory case definition
The Public Health Laboratory Network (PHLN) has developed standard case definitions for the diagnosis of key diseases in Australia. This document contains the laboratory case definition for polio. -
Creutzfeldt-Jakob disease (CJD) settlement offer
Australian Government response to the Senate Community Affairs Reference Committee's report on the Creutzfeldt-Jakob disease (CJD) settlement offer -
COVID-19 response update for General Practitioners – 18 March, 2021
This webinar on 18 March is part of a series for general practitioners on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions. -
COVID-19 vaccine update for vaccination providers – 17 March 2021
This webinar on 17 March is for vaccination providers to discuss the COVID-19 vaccine rollout. This webinar will also answer participants’ questions. -
COVID-19 response update for Carers - 23 March, 2021
This webinar on 23 March is part of a series on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions. -
COVID-19 response update for General Practitioners – 15 April 2021
This webinar on 15 April is part of a series on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions. -
COVID-19 response update for General Practitioners – 1 April 2021
This webinar on 1 April is part of a series on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions. -
COVID-19 – The new normal – 16 September
Join Dr Nick Coatsworth, Deputy Chief Medical Officer, Department of Health and a panel of guest speakers to discuss ‘COVID-19, the new normal’. -
COVID-19 response update for General Practitioners – 29 July 2021
This webinar on 29 July is part of a series on the COVID-19 response and the vaccine rollout. The panel will provide key updates and answer participants’ questions.